Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.

Blood - 15 Mar 2004

Federici Augusto B, Mazurier Claudine, Berntorp Erik, Lee Christine A, Scharrer Inge, Goudemand Jenny, Lethagen Stephan, Nitu Ioana, Ludwig Gerard, Hilbert Lysiane, Mannucci Pier M

Abstract excerpt

This study prospectively evaluated the rate of biologic response to desmopressin (DDAVP) in 66 patients with type 1 or 2 von Willebrand disease (VWD), each of whom had, on the basis of available records, a clinically significant bleeding history and at least one of the following laboratory abnormalities: bleeding time (BT) longer than 15 minutes, ristocetin cofactor activity (VWF:RCo) less than 10 IU/dL, factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Deamino Arginine Vasopressin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Europe

Share to Hemostatics

Share to Point Mutation

Share to Severity of Illness Index

Share to Treatment Outcome

Share to von Willebrand Diseases

Source

Identifiers

PMID: 14630825
DOI: 10.1182/blood-2003-06-2072

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.PMID 14630825Read ↗

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.Semantic proximity Read ↗

Response to DDAVP in children with von Willebrand disease type 2.Semantic proximity Read ↗

How I treat type 2 variant forms of von Willebrand disease.Semantic proximity Read ↗

Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group.Semantic proximity Read ↗

Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.Semantic proximity Read ↗

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.Semantic proximity Read ↗

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.Semantic proximity Read ↗

Advances in the genetics and treatment of von Willebrand disease.Semantic proximity Read ↗

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.Semantic proximity Read ↗

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.Semantic proximity Read ↗

Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease.Semantic proximity Read ↗

Von Willebrand disease in children: diagnosis and management of a pediatric cohort in one single center in Argentina.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.